Prognostic Value of Nocturnal Melatonin Levels as a Novel Marker in Patients With ST-Segment Elevation Myocardial Infarction

Alberto Dominguez-Rodriguez, Pedro Abreu-Gonzalez, Martín Garcia-Gonzalez, Russel J. Reiter

Research output: Contribution to journalArticle

18 Scopus citations


We evaluated the possible relation between circulating levels of nocturnal melatonin, C-reactive protein, and the development of adverse cardiovascular events in patients with ST-segment elevation myocardial infarction. Patients who had developed adverse events during follow-up had significantly lower nocturnal melatonin levels than patients without events.

Original languageEnglish (US)
Pages (from-to)1162-1164
Number of pages3
JournalAmerican Journal of Cardiology
Issue number8
StatePublished - Apr 15 2006


ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this